• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Hot nodes emerge in obese women

Article

While identifying sentinel nodes with lymphoscintigraphy can have a significant impact on the treatment and outcome of breast cancer, the planar imaging technique is less than optimal for overweight women.

While identifying sentinel nodes with lymphoscintigraphy can have a significant impact on the treatment and outcome of breast cancer, the planar imaging technique is less than optimal for overweight women. Multiplanar SPECT/CT lymphoscintigraphy may change that.

Dr. Hedva Lerman and colleagues at Tel Aviv Sourasky Medical Center in Israel found that overall SPECT/CT lymphoscintigraphy detects more sentinel nodes not identified with planar imaging or intraoperative blue dye. In overweight women, however, the difference was statistically significant. (JNM 2007;48[2]:201-206).

"Obesity is a significant factor in why lymphoscintigraphy fails and leads to occasional-and unnecessary-full axillary lymph node dissection," Lerman said.

Researchers don't know exactly why planar imaging fails in overweight patients, but they speculate that adipose tissue in the lymph nodes may compromise the test's accuracy.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.